10/17/2019 Symptom burden among head and neck cancer patients in the first year after diagnosis: association with primary treatment modality Allen-Ayodabo CO, Eskander A, Davis LE, Zhao H, Mahar AL, Karam I, Singh S, Gupta V, Bubis LD, Moody L, Barbera L, Coburn NG. Oral Oncol. 2019; Oct 17 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.oraloncology.2019.09.026
8/22/2019 Days spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies Cheung MC, Croxford R, Earle CC, Singh S. Leuk Lymphoma. 2019; Aug 22 [Epub ahead of print]. DOI: 10.1080/10428194.2019.1654095.
7/3/2019 Patterns of symptoms burden in neuroendocrine tumors: a population‐based analysis of prospective patient‐reported outcomes Hallet J, Davis LE, Mahar AL, Law CHL, Isenberg-Grzeda E, Bubis LD, Singh S, Myrehaug S, Zhao H, Beyfuss K, Moody L, Coburn NG. Oncologist. 2019; Jul 3 [Epub ahead of print]. DOI: https://doi.org/10.1634/theoncologist.2019-0112
The Globe and Mail11/5/2018Article Additional screening for late-stage cancer patients has little benefit, study says